InsidersTradesSigma
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
No signal scores available.
Discover the detailed record of transactions filed by Tsai John. Officer active across 1 company, notably Blueprint Medicines Corp. In total, 5 disclosures have been logged. History available since 6 January 2023. The latest transaction was disclosed on 18 June 2025 (Attribution). Regulator: SEC (Form 4). All data is openly available.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
5 of 5 declarations
Tsai John is a Director at Blueprint Medicines Corp (XNAS). The declarant has 4 filings in total, and across the 4 sampled recent filings, the period runs from 2023-01-09 to 2025-06-24; the modal transaction nature is Attribution.